Companies: 10,795·Total market cap: $144.5T
Exact Sciences Corporation

Exact Sciences Corporation

EXASNASDAQHealthcare
$104.91
+$0.00(+0.00%)
Market Cap$20.0B
P/E Ratio
52W High$104.98
52W Low$38.81

Exact Sciences Corporation(EXAS)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · EXAS · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$3.25B$2.76B$2.50B$2.08B$1.77B
Cost of Revenue$0.98B$0.84B$0.74B$0.66B$0.46B
Gross Profit$2.26B$1.92B$1.76B$1.42B$1.31B
Gross Margin %(computed)69.69%69.55%70.49%68.27%74.04%
Operating Expenses
R&D Expenses$0.52B$0.43B$0.43B$0.39B$0.39B
G&A Expenses$0.89B$1.42B$1.39B$0.66B$0.80B
Total Operating Expenses$2.36B$2.97B$1.98B$2.02B$2.16B
Operating Income($0.10B)($1.05B)($0.22B)($0.59B)($0.86B)
Operating Margin %(computed)-3.05%-38.01%-8.60%-28.48%-48.42%
Interest Income$0.04B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.03B$0.03B$0.02B$0.01B$0.01B
Income Before Tax($0.20B)($1.04B)($0.20B)($0.63B)($0.84B)
Income Tax Expense$0.00B($0.01B)$0.00B($0.01B)($0.25B)
Net Income($0.21B)($1.03B)($0.20B)($0.62B)($0.60B)
Net Margin %(computed)-6.40%-37.29%-8.17%-29.91%-33.71%
Per Share & EBITDA
EPS (Basic)$-1.10$-5.59$-1.13$-3.54$-3.48
Wtd Avg Shares0.19B0.18B0.18B0.18B0.17B
EBITDA$0.12B($0.79B)$0.03B($0.42B)($0.65B)
EBITDA Margin %(computed)3.77%-28.61%1.17%-20.20%-36.74%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Exact Sciences Corporation

关于Exact Sciences Corporation(EXAS)损益表

Exact Sciences Corporation(EXAS)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,EXAS实现营收$3.25B,毛利润$2.26B(毛利率69.69%),净利润($0.21B)(净利率-6.40%)。

常见问题

EXAS · 4 问

Exact Sciences Corporation(EXAS)2025财年营收为$3.25B,同比up17.7%。

EXAS revenueEXAS salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08